Mederer, T., Elsner, F., Robold, T., Großer, C., Neu, R., Ried, M., . . . Klein, C. A. (2022). EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patients. Lung Cancer (01695002), 167, 73. https://doi.org/10.1016/j.lungcan.2022.02.008
Chicago Style (17th ed.) CitationMederer, Tobias, et al. "EpCAM-positive Disseminated Cancer Cells in Bone Marrow Impact on Survival of Early-stage NSCLC Patients." Lung Cancer (01695002) 167 (2022): 73. https://doi.org/10.1016/j.lungcan.2022.02.008.
MLA (9th ed.) CitationMederer, Tobias, et al. "EpCAM-positive Disseminated Cancer Cells in Bone Marrow Impact on Survival of Early-stage NSCLC Patients." Lung Cancer (01695002), vol. 167, 2022, p. 73, https://doi.org/10.1016/j.lungcan.2022.02.008.